In one of the most ambitious mapping efforts in the history of radio astronomy, China’s Five-hundred-meter Aperture Spherical radio Telescope — better known as FAST — has delivered a cosmic atlas of staggering proportions. The FASHI team, headquartered at the National Astronomical Observatories of the Chinese Academy of Sciences (NAOC), has announced the second data release of the FAST All Sky HI Survey, published as a cover story in the journal Science China Physics, Mechanics & Astronomy. Just two years after the survey’s first data release catalogued 41,741 galaxies, the new edition explodes that figure to 156,411 extragalactic sources detected in neutral hydrogen — nearly a fourfold leap that firmly establishes FASHI as the largest census of atomic hydrogen gas in galaxies ever compiled.

The scale of the achievement is difficult to overstate. FASHI DR2 now spans roughly 19,500 square degrees of sky, equivalent to 47.3 percent of the entire celestial sphere, and reaches out to redshifts below z = 0.09 — distances of well over a billion light years. For comparison, the previous benchmark in this field, the ALFALFA survey conducted with the now-collapsed Arecibo telescope in Puerto Rico, charted approximately 31,500 hydrogen-bearing galaxies across about 7,000 square degrees. FASHI DR2 has thus quintupled the galaxy count of its Arecibo predecessor while covering nearly three times the sky area, and it has done so with a sensitivity roughly 0.7 times deeper than ALFALFA’s, measured as a median noise level of 0.57 mJy per beam at a velocity resolution of 6.4 kilometers per second. In radio astronomy, lower numbers mean better sensitivity — and FASHI’s numbers are among the best ever achieved in a blind, wide-area survey.

The engine behind this performance is FAST itself. With its 500-meter dish nestled in the karst hills of Guizhou Province, the telescope remains the most sensitive single-dish radio instrument on Earth at the 21-centimeter wavelength of neutral hydrogen. The survey exploited a 19-beam receiver array, allowing the telescope to sweep the sky in an efficient drift-scan mode that turned routine transits of the sky above the dish into a torrent of data. Crucially, the instrument maintained exceptional stability across five full years of observing, from August 2020 through July 2025. In surveys of this kind, calibration drifts and instrumental fluctuations can quietly corrupt weak extragalactic signals; FAST’s long-term steadiness meant that faint hydrogen emission from distant galactic disks could be stacked, averaged and trusted.

Neutral hydrogen — the primordial fuel of star formation — is invisible to optical telescopes. The 21-centimeter spectral line, produced when the electron in a hydrogen atom flips its spin relative to the proton’s, provides the only direct tracer of the cold atomic gas from which galaxies build their stars. Detecting this feeble signal across cosmological distances requires both enormous collecting area and exquisite receiver stability. A blind HI survey, unlike targeted observations, simply listens to every direction on the sky and catalogs whatever whispers back, making it an unbiased inventory of gas-rich galaxies regardless of their optical brightness, dust content or morphology. That is precisely why such surveys are prized: they catch the dim, gas-dominated dwarfs and bloated hydrogen clouds that optical catalogs systematically miss.

To give the hydrogen detections physical meaning, the FASHI team cross-matched their radio catalog with the two great optical spectroscopic endeavors of the current era: the Dark Energy Spectroscopic Instrument survey and the Sloan Digital Sky Survey. This cross-identification yielded precise optical counterparts for approximately 64,000 sources, anchoring the hydrogen detections to galaxies with measured distances, stellar masses and star-formation rates. From these matches the team constructed a completeness-corrected statistical sample of more than 109,000 galaxies — a sample robust enough to push fundamental measurements into territory previously beyond reach.

The flagship result of the release is a new measurement of the HI mass function, the statistical distribution describing how many galaxies of a given hydrogen mass populate the local universe. Thanks to the sheer sample size and FAST’s depth, the team extended the reliable measurement range of this function down to hydrogen masses of about one million solar masses — roughly 10 to the power 6.2 in solar mass units — a regime where only the faintest dwarf galaxies live. These smallest gas reservoirs are the building blocks of galaxy evolution, the raw material that hierarchically assembles larger systems, and their census has long been fragmentary. Equally striking is the derived cosmic density of neutral hydrogen: Ω_HI equals (4.71 ± 0.03 statistical ± 0.40 systematic) × 10⁻⁴ in units of h₇₀³ Mpc⁻³ dex⁻¹. The statistical uncertainty is a mere 0.6 percent — the most precise determination of the universe’s atomic hydrogen budget ever made at low redshift.

Why does such a number matter? The cosmic HI density tracks how much raw fuel exists for future star formation, and comparing its evolution across cosmic time constrains how galaxies acquire and exhaust their gas. Because atomic hydrogen sits at the interface between the intergalactic medium and the star-forming interstellar medium, its abundance is a sensitive probe of gas accretion onto dark matter halos and of the feedback processes that heat or expel gas from galaxies. Baryonic matter, after all, is hidden in far more places than stars: cold gas, warm gas, plasma in and around halos. A precision measurement of the hydrogen component anchors models of where ordinary matter resides within the cosmic web of dark matter.

The applications of the new catalog ripple far beyond that single number. For galaxy evolution studies, the 156,411 detections provide direct observational constraints on gas accretion, star formation feedback and galaxy transformation — the processes that turn blue, gas-rich spirals into passive red systems. For cosmology, the HI mass function tests galaxy formation models within the prevailing dark matter framework. For large-scale structure work, the survey complements optical galaxy catalogs to trace the so-called HI cosmic web, revealing how diffuse gas threads through filaments and pools in voids — architecture that optical surveys alone can only infer. The dataset will also aid gravitational-wave and transient science: rapid localization of the host galaxies of gravitational-wave events depends on accurate galaxy catalogs, and an inventory of hundreds of thousands of nearby galaxies sharpens those host identifications. Finally, FASHI serves as a pathfinder for the Square Kilometre Array, the giant interferometric observatory under construction in Australia and South Africa, providing benchmark samples against which next-generation interferometric surveys will calibrate their systems and select their targets.

The trajectory of the project tells its own story. When FASHI DR1 appeared, it broke ALFALFA’s long-standing record for the largest blind HI survey. With DR2, the team argues, FASHI has moved from record-breaking to benchmark-setting — a transition that observers of Chinese radio astronomy describe as the shift from follower to leader in 21-centimeter science. The cover of the journal issue reinforces the mood: a warm sunset scene evoking the faint 21-centimeter photons from distant galaxies arriving at FAST after journeys of billions of light years, messengers of the cold gas that permeates the universe.

The survey’s story is also one of institutional perseverance. The work is led by NAOC in collaboration with the Guizhou Radio Astronomical Observatory, the Shanghai Astronomical Observatory, the CAS South America Center for Astronomy, Peking University and other partner institutions, with funding from the National Natural Science Foundation of China, the Chinese Academy of Sciences and the Ministry of Science and Technology of China. Sustained national investment in a single flagship instrument has now produced a dataset whose statistical power no other facility can currently match at these wavelengths.

The full FASHI DR2 source catalog has been released to the public through the FAST data portal, a decision that will likely seed hundreds of follow-up studies in the coming years, from targeted observations of hydrogen-rich dwarfs to statistical analyses of gas in galaxy groups and environmental studies of gas stripping in clusters. As the SKA era approaches, FASHI DR2 stands as both a scientific foundation and a demonstration: that a single dish, used patiently and precisely over five years, can still redraw the map of the gaseous universe. With nearly half the sky covered and a quarter of a million more square degrees potentially within reach, the question is no longer whether FAST will extend the hydrogen frontier, but how far.

Thirty years after a small group of European professors of geriatric medicine first warned that the continent’s fastest-growing population was being cared for by physicians who had never been formally trained to care for them, the program they created to fix the problem is marking its anniversary with a scientific milestone of its own. A new special article published in European Geriatric Medicine documents the research output of the most recent graduating cohort of the European Academy for Medicine of Ageing, or EAMA, and in doing so offers a rare longitudinal measure of how a structured, pan-European leadership program in geriatric medicine translates into scholarly productivity, professional advancement and, ultimately, better care for older people.

The new paper, titled “‘Highlights of latest EAMA’: generation research outputs of the 30-year anniversary cohort,” was authored by Thomas Münzer of the Geriatric Clinic St. Gallen in Switzerland, Hannes B. Stähelin of Basel, and Barbara van Munster of the University of Groningen Medical School in the Netherlands, writing on behalf of the EAMA Board. It arrives at a moment when the demographic arithmetic of Europe has made the question of geriatric capacity more urgent than ever: the proportion of people over 65 continues to climb, multimorbidity, frailty and polypharmacy have become the daily reality of hospital medicine, and health systems across the continent still struggle to recruit and retain physicians trained specifically in the medicine of ageing. The article’s premise is simple but rarely examined with this degree of rigor — if you invest systematically in the education of mid-career geriatricians, what do you get back?

To understand the significance of the anniversary cohort’s research output, one has to go back to the early 1990s, when the group of European Professors in Medical Gerontology published a stark assessment in the journal Age and Ageing. Writing in 1994, Stähelin and colleagues documented that medical gerontology was taught unevenly, and in many countries not at all, in European medical schools. Geriatric medicine, despite being one of the few specialties whose patient population was guaranteed to expand every single year, was frequently a subordinate unit within internal medicine, staffed by physicians who had acquired their expertise on the job rather than through dedicated training. The professors’ conclusion was that Europe needed not merely more geriatricians but a new cadre of academic leaders — clinicians who could teach, publish, shape curricula and advocate for the specialty within their national health systems.

That diagnosis led, in 1995, to the founding of the European Academy for Medicine of Ageing, an intensive postgraduate program deliberately modeled on leadership academies rather than conventional continuing medical education. EAMA’s structure has remained remarkably stable across its three decades: a small, competitively selected cohort of physicians, typically already experienced clinicians, is brought together for a series of residential courses spread over roughly two years, interspersed with mentored projects that require participants to produce original scholarly work. The curriculum spans the full breadth of the medicine of ageing — from the biology of ageing and the physiology of frailty, through geriatric syndromes such as falls, delirium, incontinence and sarcopenia, to the organizational science of acute geriatric units, nursing home medicine, rehabilitation and end-of-life care. Crucially, faculty are drawn from across Europe, exposing participants to radically different national models of geriatric care and building a professional network that persists long after the formal courses end.

The “reloaded” reform of the program, described in a 2018 paper by Roller-Wirnsberger and colleagues in European Geriatric Medicine, formalized what three decades of experience had taught the academy’s faculty. That paper set out explicit competencies and standards for a European leadership program in geriatric medicine, defining what a graduate of EAMA should be able to do: not just diagnose and treat, but design services, lead multidisciplinary teams, mentor juniors, conduct and critique research, and represent the specialty at institutional and governmental levels. The competency framework aligned the academy with modern medical-education theory, in which learning objectives are specified in advance and assessed rather than assumed. It is against this framework that the anniversary cohort’s performance, as documented in the new article, can be read as an evaluation of the program itself.

The central finding of the new special article is that the latest cohort of EAMA graduates has generated a substantial body of research output — the “generation research outputs” of the title — spanning peer-reviewed publications, presentations and ongoing projects in geriatric medicine. Each participant in the program is expected to develop a scholarly project under faculty mentorship, moving from a research question through protocol design, data collection and analysis to presentation and, ideally, publication. For the 30-year anniversary cohort, the academy compiled and highlighted these outputs, creating what the authors describe as the “Highlights of latest EAMA” — a curated snapshot of what a single generation of emerging European geriatric leaders produced during and immediately after their training.

Why does this matter beyond the individual careers involved? The technical answer lies in how research capacity compounds. A single published paper changes one evidence base marginally; a cohort of trained researchers who continue publishing changes the trajectory of an entire specialty. Geriatric medicine has historically been under-represented in high-impact clinical research relative to the burden of disease it manages. Conditions such as delirium, frailty and multimorbidity were for decades excluded from major trials or treated as confounders rather than outcomes, precisely because the specialty lacked enough investigator-trained clinicians to insist on their inclusion. Programs like EAMA attack that bottleneck at its root: every graduate who learns to design a study, secure a mentor and navigate the publication pipeline becomes a node through which clinical questions from the bedside can flow into the literature and back.

The pedagogical machinery behind that outcome is worth examining, because it explains why the anniversary cohort’s productivity is treated by the authors as more than a curiosity. EAMA’s residential courses are built around case-based, small-group learning in which participants bring real clinical and organizational problems from their home institutions and work them through with international faculty. The mentored projects between courses impose deadlines and accountability — the two ingredients that, as anyone who has supervised doctoral students knows, most reliably convert good intentions into submitted manuscripts. The academy also functions as a peer-review incubator: draft papers are critiqued by senior European geriatricians before submission, giving participants exposure to the standards of international journals at a stage of their careers when feedback is most formative.

The anniversary article also carries a personal and institutional poignancy. Hannes B. Stähelin, one of the co-authors, is identified in the publication as deceased; he was among the founding professors whose 1994 analysis launched the academy, and his presence on the author line of a paper published in 2026 spans the full thirty-year arc of the program. The continuity from the GEPMG position paper through the 2002 retrospective review of the academy’s first years, published in Gerontology, through the 2018 competency framework, and now to this documentation of cohort research output, constitutes something rare in medical education: a thirty-year, multi-generation audit trail of a single intervention in specialty training, documented by the people who built it.

For health systems, the implications are concrete. Europe’s national models of geriatric care differ enormously — from the fully established departments of the United Kingdom and the Netherlands to countries where geriatrics is still fighting for recognition as an independent specialty. EAMA’s cohorts deliberately mix these national traditions, so that a geriatrician from a country without an acute geriatric unit model trains alongside colleagues who run such units daily. The research outputs of the anniversary cohort, the authors suggest, function as a form of technology transfer: projects conceived in one system are published in international journals and become adaptable blueprints for colleagues elsewhere. In an era when the European Union explicitly tracks health-workforce capacity, an academy that reliably produces clinicians who can lead services and generate evidence is a strategic asset, not a professional courtesy.

The article is also, implicitly, an argument about how educational interventions should be evaluated. Medical education research is notoriously dominated by satisfaction surveys and self-reported confidence measures, which correlate weakly with actual performance change. Research output — publications generated, projects completed, academic positions attained — is a harder, more objective endpoint, and the EAMA Board’s decision to compile and publish the anniversary cohort’s outputs signals a commitment to accountability by measurable results. It is a methodology other postgraduate leadership programs in medicine, from palliative care to rural health, could plausibly adopt: define the competencies, train against them, and then report what the trainees actually produced.

The publication timeline of the article itself — received in December 2025, revised in April 2026, accepted in June and published on 6 July 2026 in European Geriatric Medicine, the journal of the European Geriatric Medicine Society — places it squarely in the anniversary year it commemorates. As Europe’s population ages at a pace with no historical precedent, the question the founding professors asked in 1994 — who will teach the teachers, and who will lead the specialty? — has an answer that can now be pointed to in print: thirty years of EAMA cohorts, and a newest generation whose scholarly work is documented, highlighted and, the academy clearly hopes, replicated by the cohorts to come.

Every spring, Europe’s forests are showered with far more than rain. Wind-pollinated trees release staggering quantities of pollen into the atmosphere, and much of it eventually settles on leaves, branches and the forest floor. New research now shows that this pollen is not merely biological debris — it is a measurable, taxon-specific driver of nutrient fluxes in the water that drips through forest canopies, a flow scientists call throughfall. The findings, published in Environmental Monitoring and Assessment, provide the first continental-scale evidence directly linking pollen deposition to forest water chemistry, and they suggest that decades of forest monitoring may have been quietly misattributing a slice of nutrient input to other sources.

The study was carried out by a large international team led by Elena Gottardini of the Fondazione Edmund Mach in Italy, working within the ICP Forests programme, a pan-European network that monitors air pollution effects on forests. The researchers analysed throughfall samples collected in 2018 from 60 intensive monitoring plots — known as Level II plots — across eight countries: Belgium, Finland, France, Germany, Italy, Norway, Switzerland and the United Kingdom. The plots ranged in altitude from 14 to 1,900 metres above sea level and were dominated by six tree genera: Abies, Fagus, Larix, Picea, Pinus and Quercus. In total, 196 throughfall samples were collected between February and July, covering the early vegetative season when most European trees flower.

The innovation of the study lies in its methodology. Rather than inferring pollen inputs from nearby aerobiological samplers, the team examined the very same water samples that were being chemically analysed. A known quantity of water from each sample was filtered through a 5-micrometre cellulose nitrate mesh, and a calibrated number of 10-micrometre polystyrene-divinylbenzene microspheres — roughly 155,000 per sample — were added as a counting standard. The filters were then dissolved in acetone, centrifuged, and the resulting pellet embedded in fuchsin jelly on microscope slides. Trained analysts identified and counted pollen grains under 400-times magnification, stopping when about 1 percent of the added microspheres had been counted. From these counts, the team calculated pollen deposition rates in grains per square metre per day, correcting for filtered volume, throughfall quantity and sampling duration.

The results were striking. Fifty-three pollen taxa were identified across the samples, with woody species accounting for 98 percent of all grains. Four genera — Pinus, Picea, Fagus and Quercus — together made up 91.4 percent of the total. Pine pollen alone represented more than half of everything collected, a dominance the researchers attribute to the buoyant air sacs on pine grains, which allow them to travel enormous distances from both local and distant sources. In beech, spruce and pine stands, the pollen of the dominant genus itself prevailed, making up 49.7, 59.1 and 84.3 percent of the local pollen spectrum respectively. In oak stands, oak pollen ranked second at 26.9 percent, behind pine. Data from fir and larch stands were excluded because sampling there did not align with those genera’s flowering periods.

By combining the measured pollen curves with published flowering phenology, the team defined main pollen seasons for each genus. Beech and oak flowering spanned April and May, with beech peaking in the last week of April and oak showing a double peak at weeks 19 and 23, likely reflecting multiple oak species flowering at slightly different times across the wide latitudinal and altitudinal spread of plots. Spruce pollen peaked around weeks 19 to 20, while pine peaked at week 19 with a secondary pulse at week 22. Overall, 57 percent of the throughfall samples fell within their stand’s flowering period for at least half of their collection window, providing a robust temporal overlap between pollen deposition and water chemistry measurements.

The chemical analysis, conducted at the Research Institute for Nature and Forest laboratory in Belgium, quantified major ions including potassium, calcium, magnesium, sodium, chloride, phosphate, sulphate, nitrate, nitrite and ammonium using ion chromatography, alongside total dissolved nitrogen and non-purgeable organic carbon measured on a TOC/TN analyser. Linear mixed-effects models then tested whether pollen deposition rates could predict the flux of these compounds, with plot identity included as a random effect and autocorrelation between repeated samples explicitly modelled.

The answer was a clear yes. Every statistically significant association between pollen and throughfall chemistry was positive, meaning more pollen corresponded to more nutrients reaching the forest floor. Potassium emerged as the star player: its flux was significantly explained by pollen from all four main genera, with pollen accounting for an average of 33 percent of the variance. This makes biochemical sense, because potassium is one of the predominant ions in pollen grains, and pollen washed from flowers and crowns by rain or deposited dry is a direct source of the ion during the flowering season — an idea first proposed decades ago but never confirmed at this scale. The strongest single relationships involved oak pollen, which explained 77.8 percent of the variance in ammonium fluxes and 55 percent in total dissolved nitrogen.

Broadleaved and coniferous pollen left different chemical fingerprints. Beech and oak pollen together significantly explained fluxes of non-purgeable organic carbon, dissolved organic nitrogen, total dissolved nitrogen, ammonium and magnesium, while the combined pollen of pine and spruce was linked with every measured compound except phosphate. Intriguingly, broadleaved pollen showed a weak negative association with nitrate fluxes. The authors urge caution in interpreting this pattern, since several non-exclusive mechanisms could be at play. Laboratory experiments have shown that pollen and its associated microbiota can transform extracellular nitrate into nitrite and nitrous oxide, an effect pronounced in beech and oak but weak or absent in pine and spruce. Canopy uptake of nitrogen and coincidentally lower atmospheric deposition during broadleaf flowering are also possible explanations that this single-year study cannot disentangle.

The dissolved organic carbon carried in throughfall also differed by forest type. Specific ultraviolet absorbance at 254 nanometres, a proxy for aromatic and recalcitrant carbon, was highest in spruce stands, whose needles release lignin derivatives and tannins. The humification index was significantly higher in oak throughfall, reflecting more decomposed, humic organic matter. Most revealing was the fluorescence index, which distinguishes microbial from plant-derived organic matter: beech and oak samples had significantly higher values, with medians near 1.9, than pine and spruce samples, which sat near 1.7. Values above 1.9 typically indicate microbially processed carbon, and the elevated readings under broadleaves suggest microbes play a larger role in transforming pollen-derived carbon in those forests — hinting that pollen inputs feed not just trees but entire soil microbial food webs.

For the authors, the implications reach well beyond academic curiosity. Routine throughfall monitoring has historically ignored pollen as a variable, meaning that chemical enrichment previously attributed solely to canopy leaching or atmospheric deposition may in fact be partly pollenic. As climate change pushes flowering earlier and increases airborne pollen amounts across arboreal taxa, these hidden inputs could grow. Masting behaviour in beech and oak — the episodic, synchronized production of enormous seed and pollen crops — introduces strong year-to-year variability that any nutrient budget must now reckon with.

The researchers acknowledge the limitations of a one-year, correlative dataset and call for multi-year studies incorporating canopy architecture, stand age, phenology and insect infestations, as well as stable isotope tracing or controlled exclusion experiments to nail down mechanisms. Still, the message is clear: pollen is not just about reproduction, or even allergies. It is a seasonal fertiliser delivered from the sky, and forests have been banking on it all along. Incorporating pollen surveys into long-term forest observation networks, the team argues, will be essential for accurate nutrient budgets in a changing climate.

In a development that could reshape how scientists study the mechanics of human movement, a team of biomedical engineers and computer scientists has unveiled an open-source software tool capable of tracking the tiny, intricate bones of the wrist as they glide and rotate during motion. The new tool, called Hierarchical 3D Registration, or 3DH, is a module within the SlicerAutoscoperM extension of the widely used 3DSlicer computing environment. Described in a study published in BioMedical Engineering OnLine, the software was validated against previously established methods using both sequential three-dimensional computed tomography, or 3DCT, scans of living participants performing thumb tasks and dynamic four-dimensional CT, or 4DCT, images of cadaveric wrists moving through flexion and extension. The results demonstrate that the open-source approach can match the accuracy of independent, previously published methodologies while offering researchers everywhere a free and reproducible path to quantifying skeletal kinematics.

The wrist has long been one of the most challenging joints for biomechanists to study. It contains eight small carpal bones, including the scaphoid and lunate, along with the radius of the forearm and the metacarpal bones of the hand, all articulating in a tightly packed arrangement that allows the remarkable range of motion humans rely on every day. Understanding how these bones move relative to one another, a field of study known as arthrokinematics, is essential for unraveling the causes of wrist instability, osteoarthritis, ligament injuries and the long-term outcomes of surgical repairs. Yet measuring those movements in living, moving joints has historically required either invasive techniques, labor-intensive manual analysis or proprietary software that few laboratories can access or verify.

Quantitative tracking of skeletal structures in vivo, with both efficiency and high temporal resolution, matters to a wide range of questions in biomechanical research, and the authors of the new study argue that the field has been held back by a shortage of accessible, semi-automated registration tools. Image registration, the computational process of aligning one three-dimensional image volume to another, lies at the heart of motion tracking from CT data. When a bone moves between two scans, its position and orientation change, and a registration algorithm must find the transformation that best overlays the bone’s image from one time point onto the next. Done well, this yields precise measurements of rotation and translation. Done poorly or inconsistently, it introduces errors that can swamp the small movements of carpal bones, which may shift by only a few millimeters and a few degrees during normal function.

The new 3DH module addresses this problem with a hierarchical strategy for registering bones across sequences of image volumes. The researchers presented and evaluated the software using two distinct classes of data drawn from previous studies. The first consisted of sequential 3DCT datasets of human participants performing various thumb tasks, in which the radius, the first metacarpal and the trapezium were the target bones. The second consisted of dynamic 4DCT datasets capturing simulated flexion-extension motion in cadaveric wrists, providing time-resolved, three-dimensional image volumes of the scaphoid and lunate in motion. By testing the tool on both static sequential scans and true dynamic imaging, the team was able to demonstrate that 3DH is not limited to a single imaging paradigm but can serve as a unified tracking solution across modalities.

To determine whether the new open-source tool could be trusted, the investigators compared the arthrokinematics computed with 3DH against values that had been previously calculated using independent approaches for the same 3DCT and 4DCT datasets. The statistical framework for this comparison was the Bland-Altman analysis, a standard method for assessing agreement between two measurement techniques. Rather than simply correlating the two sets of results, Bland-Altman analysis quantifies the mean bias, the systematic difference between methods, and the 95 percent limits of agreement, the range within which most individual differences between the methods are expected to fall. This approach is particularly well suited to method-comparison studies because it reveals whether a new technique introduces systematic error and how widely individual measurements might deviate from those of the established gold standard.

The performance figures reported in the study are striking. For the 3DCT data, in which the radius, first metacarpal and trapezium were tracked, the mean bias for the helical angle, a single-axis description of three-dimensional rotation, was just minus 0.06 degrees, with 95 percent limits of agreement ranging between minus 1.87 degrees and 1.74 degrees. Translation measurements fared nearly as well: the mean bias was 0.12 millimeters, with limits of agreement spanning from minus 2.23 millimeters to 2.00 millimeters. In practical terms, the open-source tool reproduced the rotational and translational measurements of the earlier methods to within roughly two degrees and two millimeters at the extremes, differences small enough to preserve the biological signal in most wrist kinematics experiments.

The dynamic 4DCT results told a similar story for the carpal bones. Tracking the scaphoid and lunate through simulated flexion-extension, 3DH produced mean biases of the Euler angle rotations, which decompose three-dimensional rotation into three orthogonal components, of less than 0.77 degrees about any direction. The widest 95 percent limits of agreement ranged between minus 7.11 degrees and 8.65 degrees. For translations, mean biases were less than 0.5 millimeters in any direction, with the widest limits of agreement ranging between minus 2.36 millimeters and 1.43 millimeters. The wider limits of agreement for rotations in the dynamic data likely reflect the added challenges of time-resolved imaging, including motion blur and the smaller, more complexly shaped carpal bones, but the near-zero mean biases indicate that the tool does not systematically drift away from established values.

Crucially, all target bones were successfully tracked in both the 3DCT and 4DCT datasets, meaning the hierarchical registration algorithm converged on correct solutions in every case tested. This robustness matters because registration algorithms can occasionally fail, locking onto incorrect alignments or diverging entirely, and such failures typically demand time-consuming manual intervention. A semi-automated tool that reliably succeeds across diverse bones, motion tasks and imaging protocols removes a significant bottleneck. Manual bone tracking in CT volume sequences can take hours per bone per trial, and the labor multiplies rapidly in studies involving multiple participants, multiple bones and dozens of motion cycles. By automating this process within a validated framework, 3DH promises to accelerate the pace at which wrist biomechanics data can be collected and analyzed.

The choice to build the module inside 3DSlicer, and specifically within the SlicerAutoscoperM extension, is a deliberate strategic decision with implications well beyond the wrist. 3DSlicer is a free, open-source platform for medical image computing and visualization with a large international user base spanning research, clinical and educational communities. By embedding 3DH in this ecosystem, the developers have made the tool immediately available to any laboratory already working with 3DSlicer, complete with the platform’s established infrastructure for loading DICOM data, segmenting anatomical structures and visualizing results. The authors note that the ability to track bones from both 3DCT and 4DCT data sources, with agreement to prior methodologies, demonstrates that the 3DH approach is a capable tool that could promote collaboration and consistency of results through open-source software.

Consistency is a quietly urgent issue in biomechanics. When different laboratories use different proprietary tools with undisclosed algorithms, it becomes difficult to distinguish true biological differences between study populations from mere methodological discrepancies. Open-source registration changes that calculus: the code can be inspected, verified, extended and reused, and results from different institutions become directly comparable because they are produced by identical algorithms. This transparency also lowers the barrier to entry for research groups in settings that cannot afford commercial licenses, potentially broadening the global community capable of conducting rigorous skeletal kinematics research.

The study itself emerged from a collaboration spanning several institutions. The team included Joseph J. Crisco, Amy M. Morton and John D. Holtgrewe of the Department of Orthopedics at The Warren Alpert Medical School of Brown University and Rhode Island Hospital; Cesar Lopez, Andrew Thoreson and Kristin D. Zhao of the Assistive and Restorative Technology Laboratory and the Department of Physical Medicine and Rehabilitation at the Mayo Clinic in Rochester, Minnesota; and Jean-Christophe Fillion-Robin and Beatriz Paniagua of Kitware Inc. in Clifton Park, New York. The involvement of Kitware, a company known for its leadership in open-source scientific computing, underscores the blend of academic rigor and software engineering expertise required to produce a research tool robust enough for widespread distribution. Funding was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under award numbers AR059185, AR078924 and AR071338.

The implications of this work extend naturally to the future of musculoskeletal imaging. As newer CT technologies, including photon-counting detector systems, deliver ever-finer spatial resolution and as dynamic 4DCT becomes more widely available, the volume of image data available for kinematic analysis will grow dramatically. Tools like 3DH, which are fast, semi-automated and validated across modalities, will be essential for converting that imaging bounty into quantitative biomechanical knowledge. For patients with wrist disorders, the downstream promise is equally tangible: better measurements of how carpal bones actually move in living joints can inform more accurate diagnoses, improved surgical planning, more realistic computational models of joint loading and ultimately better-designed treatments for conditions ranging from scapholunate instability to thumb-base arthritis. With the tool now openly available in the 3DSlicer environment, researchers around the world can begin putting it to work.

If you’re one of the many people chowing down on melatonin gummies to help get to sleep, you may want to check out this study.

A new piece of research published by the American Heart Association made an alarming discovery about long-term use of melatonin supplements, an over-the-counter sleep aid used by tens of thousands. Basically, those who use melatonin over a year or more had a 90 percent higher risk of developing congestive heart failure over a five-year period.

Before you go flush your gummies down the toilet, there are a few caveats. For starters, the findings weren’t based on a clinical trial, but on data from a large database of anonymous health records. Researchers drew from data on chronic insomniacs, specifically, splitting them into two groups: those who have dosed the sleep-regulating hormone over a period of 12 months or more, and those who suffer without.

Still, the results are clearly worrisome. Overall, the study found that 4.6 percent of the melatonin group went on to develop heart failure, compared to 2.7 percent for the control group.

That wasn’t the only data point suggesting it may be time to wean off the ‘tone. A secondary analysis performed by the researchers found that melatonin users were nearly 3.5 times more likely to be hospitalized for heart failure than those in the other group, with hospitalization rates of 19.0 and 6.6 percent, respectively.

“Melatonin supplements are widely thought of as a safe and ‘natural’ option to support better sleep, so it was striking to see such consistent and significant increases in serious health outcomes, even after balancing for many other risk factors,” Ekenedilichukwu Nnadi, the study’s lead author and chief resident in internal medicine at SUNY Brooklyn, said in a press release.

While more in-depth research is needed to confirm the study’s results, the early findings indicate that melatonin use comes with some serious risks in the long-term.

“Melatonin supplements may not be as harmless as commonly assumed,” as Nnadi explained. “If our study is confirmed, this could affect how doctors counsel patients about sleep aids.”

More on health studies: The Hectic Modern World Is Shredding Your Little Cave Man Brain, Scientists Confirm

The post Melatonin Use Linked to Massively Increased Risk of Heart Failure appeared first on Futurism.

In Boé National Park, researchers have repeatedly encountered a small number of trees marked by gouged bark and piles of stones at their bases. These signs suggest that wild chimpanzees have returned to the same trees for years to throw rocks. According to a recent field account by University of Victoria researchers Robyn Nakano and Ammie Kalan, some of these sites have remained in use for over a decade.

This behavior, called accumulative stone throwing, has been observed in only four chimpanzee populations in West Africa. While rocks and trees are widespread in chimpanzee habitats, piling stones at specific trees is rare. Nakano, Kalan, and other researchers suggest this may be a cultural practice within certain groups rather than arising from environmental factors alone.

What the Behavior Looks Like

Video recordings collected through the Pan African Programme and analyzed in a 2016 Scientific Reports study led by Hjalmar Kühl show that mostly adult male chimpanzees throw rocks at particular trees and repeatedly return to the same trunks. During these events, the chimpanzees pant-hoot, a loud call used for long-distance communication, and sometimes perform buttress drumming by repeatedly striking the tree’s buttressed base with their hands and feet.

Pant-hooting and buttress drumming are typical features of displays put on by male chimpanzees. The fact that these behaviors occur alongside stone throwing suggests that accumulative stone throwing may have developed as a variation of these existing social displays.

A Ritualized Behavior, Not a Coincidence

Researchers suspect this behavior may be cultural rather than simply a response to environmental conditions because it occurs only in certain areas, even though appropriate rocks and trees are common throughout chimpanzees’ habitats. Within one population, only particular trees are used as throwing sites. Earlier studies have suggested that the behavior might function as a form of communication or could indicate places of symbolic significance within a community’s territory.

The behavior could also offer archaeologists a rare example of how repeated stone use and accumulation can create material traces that persist after the animals that made them have moved on.

Some primates use stones as tools, including populations that use rocks to open nuts for food. Accumulative stone throwing differs because the behavior occurs in a social context rather than during extractive foraging. The purpose of this behavior for the chimpanzees remains unclear.

Into the Boé Wilderness

Nakano and Kalan conducted their fieldwork from Béli, a village where the Dutch nonprofit Chimbo operates a solar-powered research compound with local partners. The team traveled 22 kilometers by bicycle and on foot into the savanna-woodland to establish a camp, working with field assistants Djei Baldé, Balu Séra, and master’s student Taylor Tippett from the Great Ape Behaviour Lab.

The Boé chimpanzees are not used to humans and tend to avoid them, making direct observation impossible. The team instead set up two video cameras at each known stone-throwing site and placed audio recorders nearby to monitor the area.

Each day began at 6:30 a.m. with visits to two to five sites to replace SD cards and batteries, check equipment, measure trees, and create 3D scans of rocks thrown at the trees for later analysis. The team also recorded chimpanzee nests, feeding traces, and vocalizations along the trails. Their camp was located beside the Fefine River, which continues flowing through the dry season and provides an important water source for wildlife.

A Decade of Stone Throwing

The team found that most sites first identified by the Pan African Programme and revisited in 2017 remained active when Nakano and Kalan’s team returned in 2026. Chimpanzees have returned to these same trees to throw rocks for more than ten years.

The video and audio collected during this trip will allow the team to identify the age and sex of individual stone-throwers and observe how nearby chimpanzees respond to these events. This data could help the researchers determine the purpose of this behavior.

A Landscape Under Threat

Chimpanzees’ habitat in Guinea-Bissau is becoming increasingly threatened by industrial mining. During fieldwork, the researchers discovered boreholes dug to explore bauxite, the ore used to produce aluminum. Although bauxite mining might help promote economic development, comparable operations in neighboring Guinea have caused habitat loss and pollution, with negative effects on both wildlife and local communities. The country’s political instability also presents challenges for environmental oversight.

Nakano and Kalan emphasize that losing these stone-throwing sites would be both a cultural and ecological loss, erasing a documented example of primate material culture.

What’s Still Unknown

Nakano and Kalan are still analyzing the footage from this field season, but the main question of why chimpanzees throw stones at these specific trees remains unanswered. Still, the evidence collected by the cameras and recorders could help determine whether the behavior functions as territorial signaling, long-distance communication, or something else entirely.

Austin Burgess is a writer and researcher with a background in sales, marketing, and data analytics. He holds an MBA, a Bachelor of Science in Business Administration, and a data analytics certification. His work focuses on breaking scientific developments, with an emphasis on emerging biology, cognitive neuroscience, and archaeological discoveries.

The Marcus Foundation has awarded $28.7 million to Chuck Murry, MD, PhD, director of the USC Stem Cell Center, to support a clinical trial testing a stem cell-based therapy intended to regenerate heart muscle damaged by a severe heart attack. The award, the largest the foundation has given to the University of Southern California and one of its largest contributions to academic medicine, will fund both the planned human study and a parallel research program examining how the immune system responds to transplanted cardiac cells.

The trial is scheduled to begin in 2027 at Keck Hospital of USC in partnership with the USC Cardiac and Vascular Institute. A second clinical site will be established at the University of Washington, where elements of the technology were originally developed. The first phase will enroll approximately 18 patients who have experienced extensive myocardial infarction, the medical term for a heart attack that destroys part of the heart’s muscular wall.

Patients in the study will receive stem-cell-derived heart muscle cells delivered into regions damaged by the infarction. The primary goals will be to evaluate safety and determine whether the procedure is feasible in people with severe cardiac injury. Investigators will also monitor early biological signals, including whether the transplanted cells remain active, integrate with the injured tissue and produce measurable changes in cardiac performance during recovery and long-term follow-up.

A heart attack occurs when blood flow through a coronary artery is blocked, depriving cardiac muscle of oxygen. Within minutes, cells in the affected region begin to die, and the resulting scar tissue lacks the contractile properties of healthy myocardium. Unlike tissues such as skin or blood, adult human heart muscle has only a limited capacity for self-repair. As a result, a large infarction can weaken the heart’s pumping function, increase the risk of heart failure and leave survivors unable to perform ordinary activities without fatigue or breathlessness.

Current cardiovascular treatments can reopen blocked arteries, limit further injury and help the remaining heart muscle work more efficiently. They cannot, however, routinely replace the cardiomyocytes that have already been lost. Murry’s research program is aimed at addressing that biological gap by producing replacement heart muscle cells in the laboratory and delivering them directly to damaged tissue. The strategy represents a shift from supporting a failing heart to attempting to rebuild part of its contractile apparatus.

The transplanted cells are being developed as a form of cellular therapy, in which living cells act as the therapeutic agent rather than serving merely as a vehicle for a drug. According to Murry, the cells are intended to become active within the injured heart, contribute to repair and synchronize with surrounding muscle. Achieving that outcome requires more than placing new cells into scarred tissue: the cells must survive, connect functionally with the host myocardium and avoid creating dangerous electrical disturbances or abnormal rhythms. The initial trial is therefore designed principally to establish safety before testing therapeutic effectiveness in larger patient groups.

The foundation’s funding will also support research into the immune response triggered by cell transplantation. Even cells created from stem cells can be recognized as foreign by the recipient’s immune system, potentially leading to inflammation or destruction of the transplanted population. Patients who receive cellular grafts may consequently require immunosuppressive drugs, which can increase susceptibility to infection and produce other long-term complications. Researchers will study how immune cells interact with the implanted cardiac cells and investigate methods that could reduce or eventually eliminate the need for chronic immunosuppression.

The work builds on approximately three decades of research by Murry and his collaborators to move regenerative cardiology from laboratory experiments toward clinical treatment. The program includes gene-edited cellular technology, intended to improve the compatibility or performance of therapeutic cells in the human body. The precise effectiveness of the approach will not be known until it is tested in patients, and the small 2027 cohort will not be large enough to determine whether the therapy improves survival or prevents heart failure. Those questions would require subsequent trials involving substantially more participants and longer observation.

The Marcus Foundation described the project as a potential turning point for regenerative medicine, while USC leaders said the investment could create a platform for developing additional cellular therapies. The immediate scientific challenge is to determine whether transplanted heart muscle cells can be delivered safely and function meaningfully within severely damaged human hearts. If the trial meets its safety and feasibility objectives, it could provide the clinical evidence needed to advance a new generation of treatments for myocardial infarction—therapies designed not only to help patients live with damaged cardiac tissue, but to restore some of the function that conventional medicine cannot yet replace.

Subject of Research: Stem cell-based regenerative therapy for heart muscle damaged by myocardial infarction

Article Title: $28.7 Million Award Supports USC Trial of Stem Cell Therapy to Regenerate Heart Muscle After Heart Attack

Web References: The Marcus Foundation: https://marcusfoundation.org/; USC Stem Cell Center: https://stemcell.keck.usc.edu/; Chuck Murry Lab: https://murrylab.usc.edu/charles-chuck-murry-md-phd/; USC Cardiac and Vascular Institute: https://www.keckmedicine.org/services/cardiovascular/; Keck School of Medicine of USC: https://keck.usc.edu/

Image Credits: Steve Cohn

Keywords: Heart disease, myocardial infarction, heart attack, heart muscle, stem cell research, stem cell therapy, cell therapy, regenerative medicine, cardiovascular disorders, heart failure, clinical trial, cardiac regeneration

A climate shock that unfolded about 304 million years ago is offering scientists a dramatic warning about how quickly Earth’s climate system can amplify an initial temperature rise. During the Late Paleozoic Ice Age, a relatively modest increase in global temperatures appears to have triggered a much larger episode of warming, as methane released from thawing permafrost intensified the greenhouse effect. Researchers say the ancient event provides a powerful geological parallel for the climate changes occurring today.

The study, led by Le Yao of the Nanjing Institute of Geology and Paleontology with contributions from University of Cincinnati geosciences professor Thomas Algeo and international colleagues, examined a short-lived warming episode during Earth’s penultimate ice age. Their findings suggest that global sea surface temperatures eventually increased by more than 7 degrees Celsius, or approximately 12 degrees Fahrenheit. The rise was not necessarily caused by one enormous initial pulse of carbon. Instead, it may have developed through a chain reaction in which warming activated additional natural sources of greenhouse gases.

The Late Paleozoic Ice Age extended across a vast span of geological time, when large ice sheets covered parts of the supercontinent Gondwana. Although the planet was in an “icehouse” state, atmospheric carbon dioxide and methane still had the power to destabilize the climate. The newly analyzed warming event is particularly significant because it occurred under ice-age conditions rather than during an already warm greenhouse world. That makes it a valuable analog for the modern Earth, which still contains continent-scale ice masses in Greenland and Antarctica.

According to the researchers, the initial climate disturbance may have been linked to volcanic activity. Volcanic emissions can inject carbon dioxide and other gases into the atmosphere, where they absorb outgoing infrared radiation and prevent some heat from escaping into space. The warming may also have been assisted by changes in Earth’s orbit. Over long cycles, variations in orbital shape alter the distribution of sunlight across the planet, influencing the growth and retreat of ice sheets and changing the seasonal balance of solar energy.

At first, the additional carbon may have produced only a limited temperature increase. But once warming crossed a critical threshold, frozen ground in high-latitude regions began to thaw. Permafrost contains large quantities of organic carbon preserved in frozen soils. When that material becomes available to microbes, decomposition can release carbon dioxide and methane. Methane is especially powerful over shorter atmospheric timescales because, molecule for molecule, it absorbs considerably more infrared radiation than carbon dioxide, even though it remains in the atmosphere for less time.

This process can create a positive climate feedback. An initial warming causes permafrost to thaw, thawing releases greenhouse gases, and the additional gases produce further warming. That extra heat can accelerate more thawing, allowing the cycle to reinforce itself. The researchers describe the ancient event as a transient global warming episode in which a comparatively modest carbon release appears to have crossed a climatic tipping point and initiated much more extensive carbon emissions from natural reservoirs.

The geological timescale of the ancient warming is also central to the study’s relevance. Algeo said the temperature change unfolded over tens of thousands of years, with warming occurring at an average rate of roughly one-tenth of a degree Celsius per 1,000 years. Modern warming is progressing far more rapidly. Researchers have observed an increase of nearly 1 degree Celsius in global sea surface temperature over approximately the past century, a rate many times faster than the average change reconstructed for the ancient event.

The comparison does not mean that Earth is destined to repeat the precise conditions of 304 million years ago. Continents, ecosystems, atmospheric composition and ice-sheet geometry were all different in the Late Paleozoic. However, the physics of greenhouse warming and the existence of carbon feedbacks remain relevant. Ancient climate records reveal how a system that appears stable can respond nonlinearly when warming activates processes capable of releasing additional greenhouse gases.

The findings also place human history in a broader planetary context. All recorded human civilization has developed during the most recent ice age, despite the fact that the term can sound incompatible with today’s climate. In scientific usage, Earth remains in an ice age because substantial permanent ice sheets still exist in Greenland and Antarctica. The ancient warming episode matters precisely because it demonstrates that an ice age does not guarantee a permanently cold or stable climate. Even within an icehouse world, a small disturbance can trigger rapid and substantial changes when reinforcing feedbacks are engaged.

The research, published in the Proceedings of the National Academy of Sciences, underscores why scientists closely monitor permafrost, polar ice and other climate-sensitive carbon stores. The ancient record cannot provide an exact forecast of future warming, but it shows that Earth’s climate has repeatedly responded to carbon disturbances with amplifying feedbacks. As modern emissions continue to raise temperatures at an exceptional rate, the geological evidence offers a clear message: the danger lies not only in the carbon released directly by human activity, but also in the natural carbon sources that warming can unlock.

Subject of Research: Ancient global warming, permafrost methane feedbacks, and climate tipping points during the Late Paleozoic Ice Age

Article Title: A transient global warming event during Earth’s penultimate icehouse

Web References: https://doi.org/10.1073/pnas.2601643123

References: Proceedings of the National Academy of Sciences, DOI: 10.1073/pnas.2601643123

Image Credits: Andrew Higley, University of Cincinnati

Keywords: climate change, global warming, ice age, Late Paleozoic Ice Age, permafrost, methane, climate feedback, tipping point, paleoclimate, geology, volcanic activity, Earth’s climate history

A research team in Japan has won a US$1 million Milestone 2 award in the XPRIZE Healthspan competition for developing engineered “super exosomes,” microscopic biological delivery vehicles designed to target aging and damaged cells. Led by Professor Keisuke Goda of Tohoku University’s SiRIUS Institute of Medical Research and Graduate School of Medicine, in collaboration with researchers from the University of Tokyo’s Department of Chemistry, the team was selected from more than 600 competitors worldwide.

XPRIZE Healthspan is a seven-year international competition focused on extending the period of life people spend in good health. Participating teams are challenged to develop treatments capable of restoring muscle, cognitive, and immune function in adults between 50 and 90 years old. The competition sets a minimum target of reversing at least 10 years of biological decline, while the most ambitious goal is a 20-year improvement within one year or less of treatment. Goda’s team is now moving forward after receiving recognition for results obtained in aged animal studies.

At the center of the research are exosomes, naturally occurring nanoparticles released by cells. These membrane-bound vesicles normally transport proteins, lipids, messenger RNA, and other molecular signals between cells, functioning as part of the body’s communication network. Because exosomes can carry biological cargo and interact with specific tissues, scientists have been investigating them as potential alternatives to synthetic drug-delivery systems. However, naturally produced exosomes often lack sufficient targeting precision, limiting their ability to reach the cells most relevant to a disease or aging process.

The Tohoku-led group attempted to solve that problem by chemically modifying the surface of exosomes with lanthanide ions. Lanthanides are a family of metallic elements with distinctive electronic and chemical properties. According to the researchers, attaching these ions changes the surface behavior of the exosomes and substantially improves their ability to recognize and bind to senescent cells. The resulting particles have been named “super exosomes,” a term that reflects their enhanced targeting and delivery capabilities rather than a new biological category.

Cellular senescence is one of the major biological processes associated with aging. Senescent cells have generally stopped dividing because of accumulated damage or stress, but they do not necessarily disappear. Instead, some remain metabolically active and release inflammatory molecules, growth regulators, and other signals that can disrupt nearby tissues. This collection of secreted factors, often called the senescence-associated secretory phenotype, can contribute to chronic inflammation, impaired tissue repair, and the deterioration of organs. Precisely influencing these cells has therefore become a major objective in longevity research.

The proposed super-exosome platform is designed to deliver regenerative molecular cargo directly to aging tissues after attaching to senescent cells. Potential cargoes include growth factors, messenger RNA, and other genetic materials capable of altering cellular behavior. Rather than distributing such molecules broadly throughout the body, a targeted exosome could concentrate them near damaged or dysfunctional tissue. In theory, this approach could promote repair while reducing unwanted effects in healthy cells, although the degree of targeting and the durability of the response will need to be confirmed in human studies.

In preclinical experiments involving several groups of aged mice, the researchers reported statistically significant improvements in frailty, physical performance, and multiple functional measures associated with aging. They also described the treatment’s safety profile as excellent in the studies conducted so far. The team says the overall benefit corresponds to more than 15 additional healthy human years when estimated using cross-species lifespan scaling. Such calculations can help compare biological effects between species, but they are not evidence that a mouse treatment will extend human life by a specific number of years. Human biology, dosing, immune responses, and long-term risks could differ substantially.

The award will support the next stage of development: clinical studies planned in collaboration with Tohoku University Hospital and the Tohoku University Healthspan Research Center. These studies will need to establish how the particles behave in humans, how efficiently they reach senescent cells, what cargoes are most effective, and whether the treatment produces measurable improvements in strength, cognition, immunity, or other healthspan indicators. Researchers will also have to monitor possible immune reactions, unintended effects on healthy tissues, changes in tumor risk, and the persistence of engineered exosomes in the body. These questions are essential before claims of age reversal can move beyond the laboratory.

The platform could eventually be investigated for conditions involving muscle decline, cognitive impairment, immune dysfunction, hair loss, skin aging, and reproductive health. The team plans to commercialize the technology through NanoTitan, with the aim of developing scalable manufacturing and international distribution for exosome-based therapeutics produced in Japan. “Advancing to the XPRIZE Healthspan finals is an important milestone, but our ultimate goal is to translate this technology into therapies that allow people to lead healthy, independent, and active lives longer,” Goda said. The research now enters its most demanding phase: determining whether an impressive result in aged mice can become a safe, reproducible, and clinically meaningful treatment for people.

Subject of Research: Engineered “super exosomes” designed to target senescent cells and deliver regenerative molecular cargo for healthy aging.

Article Title: Japanese Research Team Wins US$1 Million XPRIZE Award for “Super Exosome” Aging Technology

Web References: https://mediasvc.eurekalert.org/Api/v1/Multimedia/673c8fb3-268a-4a90-93b4-a0d531624a52/Rendition/low-res/Content/Public

Image Credits: Goda Lab

Keywords: Super exosomes, exosomes, cellular senescence, healthy aging, longevity research, XPRIZE Healthspan, regenerative medicine, Tohoku University, lanthanide ions, aged mice, healthspan, nanomedicine

The apparent benefits of updated COVID-19 vaccines in older adults may be influenced by more than the vaccines themselves, according to a study examining the “healthy vaccinee effect,” a form of bias that can complicate observational research. Published in Nature Communications, the work by Lyth, Spreco, Hinkula and colleagues focuses on how differences between people who receive vaccination and those who do not can alter estimates of vaccine effectiveness, particularly in elderly populations whose health status can change rapidly.

Updated COVID-19 vaccines are designed to improve protection against circulating SARS-CoV-2 variants, especially protection against severe disease, hospitalization and death. Because randomized clinical trials are not usually repeated for every reformulated vaccine and every emerging variant, researchers frequently rely on real-world health data. These studies compare outcomes among vaccinated and unvaccinated people, but the two groups may differ in important ways before vaccination occurs. Such differences can produce an apparent vaccine benefit—or obscure a real one—even when the analysis carefully accounts for age and medical conditions.

The healthy vaccinee effect arises when people who are vaccinated are temporarily healthier, more active or better connected to healthcare services than those who remain unvaccinated. Individuals may postpone vaccination during an acute illness, after hospitalization or when they are approaching the end of life. At the same time, people who attend vaccination appointments may be more likely to receive preventive care, follow medical advice and seek treatment early. These characteristics are not necessarily caused by vaccination, but they can lower the vaccinated group’s risk of death or hospitalization during the period used for analysis.

This issue is particularly important in older populations. Elderly people often have multiple chronic conditions, fluctuating functional status and frequent contact with hospitals or long-term care facilities. A person may be eligible for a vaccine campaign but unable to receive the dose because of an acute health problem. If that person later dies or is hospitalized, conventional analyses may attribute the worse outcome to the absence of vaccination, even though the underlying illness was already present. Conversely, if researchers compare groups immediately after vaccination without accounting for this selection process, the vaccine may appear more protective than it truly is.

The study evaluates how this bias affects assessments of updated COVID-19 vaccines in elderly populations. Its central scientific contribution is to treat vaccination not simply as an exposure, but as an event embedded in a changing health trajectory. The health of older adults is not static: frailty, infection, recent hospitalization and access to care can all influence whether and when vaccination occurs. By examining these time-dependent factors, the researchers draw attention to the difference between a vaccine’s biological effect and the characteristics of the people who are able to receive it at a particular moment.

In epidemiological terms, the healthy vaccinee effect is a form of confounding and selection bias. Confounding occurs when another factor is associated with both vaccination and the outcome being measured. Selection bias occurs when inclusion in the vaccinated or comparison group depends on health-related circumstances. Timing can intensify both problems. If follow-up begins on the day of vaccination for one group but at an arbitrary date for another, the groups may not have equivalent baseline risks. Researchers therefore need to define an appropriate index date, align observation periods and account for recent illness, healthcare use and changes in eligibility.

The challenge is not merely statistical. A vaccine can provide strong protection against severe COVID-19 while producing a smaller or more variable effect against infection, depending on the variant, time since vaccination, prior immunity and the outcome being studied. If an observational analysis reports a lower mortality rate among vaccinated people, that result may reflect a combination of direct vaccine protection and the healthier profile of vaccine recipients. Separating these components requires careful design, including adjustment for measured risk factors and, where possible, comparison strategies that mimic a randomized trial.

The findings have practical implications for interpreting public-health evidence. Estimates of updated vaccine effectiveness should not be read in isolation from the population being studied, the timing of vaccination and the definition of the unvaccinated comparison group. Researchers may need to conduct sensitivity analyses, use negative-control outcomes, examine short intervals after vaccination and account for healthcare-seeking behavior. Analyses that compare people with similar recent health histories, or that use methods designed for time-varying confounding, can help determine whether an observed association is likely to represent a genuine vaccine effect.

The study does not undermine the value of COVID-19 vaccination for older adults; rather, it highlights the methodological care required to measure that value accurately. For clinicians, policymakers and the public, the message is that real-world vaccine evidence is strongest when biological protection is evaluated alongside the circumstances that determine who gets vaccinated and when. As SARS-CoV-2 continues to evolve and vaccine formulations are periodically updated, understanding the healthy vaccinee effect will remain essential for distinguishing the protection delivered by immunization from the protection that appears because healthier people are more likely to receive it.

Subject of Research: Healthy vaccinee effect and the evaluation of updated COVID-19 vaccines in elderly populations.

Article Title: Healthy vaccinee effect in the evaluation of updated COVID-19 vaccines in elderly populations.

Article References:

Lyth, J., Spreco, A., Hinkula, J. et al. Healthy vaccinee effect in the evaluation of updated COVID-19 vaccines in elderly populations. Nat Commun 17, 8014 (2026). https://doi.org/10.1038/s41467-026-76312-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41467-026-76312-x

Keywords: COVID-19 vaccines, updated vaccines, SARS-CoV-2, elderly populations, healthy vaccinee effect, vaccine effectiveness, epidemiology, observational studies, confounding, public health.

No, there weren't "2,700 heatwave deaths due to climate change", says Ben Pile – a figure conjured by Met Office and Imperial College modelling. But nobody must be allowed to remember the warm days of 2026 fondly.

The post No, There Weren’t “2,700 Heatwave Deaths Due to Climate Change” appeared first on The Daily Sceptic.

If you drive, your car’s tires are shredding more than just tread: they may be mincing up our grey matter too.

New research by a team in China discovered an alarming link between a chemical commonly found in tires and the onset of Alzheimer’s disease. The chemical, called 6PPD-Q, is formed when fine tire particles meet ozone. That happens anytime new chunks of tire are exposed to the air, meaning the particle may be nearly ubiquitous in car-heavy environments.

According to the findings, recently published in the journal Open Medicine, when the ozone-treated chemical meets our brain cells, it can cause oxidative stress — wear and tear, basically — and inflammation, while also reducing how effectively individual cells “communicate” with one another. These factors strongly correlate to the development of early-stage Alzheimer’s, suggesting anyone who regularly comes into contact with rubber tires may be inadvertently exposing themselves to brain-altering chemicals.

For those in car-dependent regions of the world like North America, that’s a pretty significant chunk of the population.

The chemical makes its way into our brains through our blood, which it enters primarily when we breathe in dust particles laden with 6PPD-Q. Other avenues of exposure include crops and soil, stadium turf, working near highways or with cars, and contact with recycled tire products.

While scientists already knew that 6PPD-Q interacts with the brain somehow, the chemical’s newfound molecular connection to Alzheimer’s is significant. Using machine learning software, the team mapped how effectively the chemical binds to five “Alzheimer predictor genes,” finding that 6PPD-Q forms strong bonds with three.

Beyond humans, 6PPD-Q run-off from roadways is having a sizable impact on fish populations, notably salmon. One 2022 study on the environmental journey road runoff takes described the substance as a “highly toxic tire-derived chemical,” which has caused “mass mortalities of coho salmon,” specifically.

Going forward, scientists still need to conduct broader lab tests on human cells in order to figure out how severely various quantities of 6PPD-Q contribute to Alzheimer’s disease. Only then can we get a sense of just how risky it is to burn rubber.

More on pollution: Amazon Is Spewing a Record Breaking Amount of Pollution to Power Its AI Data Centers

The post Learning What Substance Is Suspected of Causing Alzheimer’s May Throw You Into an Existential Crisis appeared first on Futurism.

Human laughter may hold a deeper connection to our primate ancestors than previously realized, preserving a 15-million-year-old evolutionary legacy. New research from the University of Warwick suggests the rhythm of laughter has remained largely unchanged across millions of years, offering surprising new insights into the origins of human speech.

Great apes are humanity’s closest living relatives, and species including chimpanzees, bonobos, gorillas, and orangutans all produce laughter-like vocalizations accompanied by smile-like facial expressions.

For years, scientists have wondered whether these vocal expressions share a common evolutionary origin. To investigate, researchers analyzed laughter recordings from 17 apes and humans representing five species: four orangutans, two gorillas, three bonobos, four chimpanzees, and four humans. Examining 140 laughter sequences, they found that every species produced laughter with evenly spaced rhythmic intervals between sounds—a pattern that appears to have been inherited from a common ancestor.

“It is impossible to assess the precursor forms of language directly from our extinct ancestors,” said Dr Adriano Lameria, an Associate Professor with the Department of Psychology at the University of Warwick and a researcher with its ApeTank, said in a statement. “Laughter, being evolutionarily older and having remained shared between all living great apes, provides a rare evolutionary window into the vocal transformations that unfolded across hominid evolution until the first humans appeared on scene.”

“Contrary to the classic notion that the first humans suddenly acquired vocal control capacities remarkably different from their predecessors, laughter evolution tells us that humans lay on a continuum, a prolongation of vocal control capacities that were already being cumulatively honed in for 15 million years,” Lameria added.

The discovery suggests that this rhythmic connection and foundation of laughter was already present around 15 million years ago and has persisted through millions of years of evolutionary change.

“How did humans evolve the remarkable ability to speak? Speech leaves no fossils, and complex language exists only in our own species. But we’ve found a 15-million-year-old clue in an unexpected place: our laughter,” said Dr. Chiara De Gregorio, Honorary Research Associate, Department of Psychology, University of Warwick. 

“Unlike speech, laughter is shared by all living great apes. By comparing how different species laugh, we can see that a basic rhythmic structure has remained unchanged since our last common ancestor. That’s extraordinary,” De Gregorio added.

Even though humans and apes share similarities—with ape vocalizations generally having a deeper resonance and tone—the underlying timing of laughter has remained remarkably stable over millions of years. What distinguishes humans is our greater voluntary control over laughter, allowing us to laugh intentionally in social situations in ways that our primate relatives cannot.

Scientists believe this increased vocal control may have played a key role in the evolution of speech. The human ability to precisely regulate vocal timing, tone, and expression is considered a fundamental component of producing complex spoken language.

The new findings challenge the idea that humans suddenly developed advanced speech abilities unlike those of earlier species. Instead, the research suggests that human communication evolved gradually, building upon vocal capacities that had already been developing in our ancient primate relatives.

Chrissy Newton is a PR professional and the founder of VOCAB Communications. She currently appears on The Discovery Channel and Max and hosts the Rebelliously Curious podcast, which can be found on YouTube and on all audio podcast streaming platforms. Follow her on X: @ChrissyNewton, Instagram: @BeingChrissyNewton, and chrissynewton.com. To contact Chrissy with a story, please email chrissy @ thedebrief.org.

In a groundbreaking decade-long study analyzing São Paulo’s urban landscape, researchers have revealed how the expansion of bike lanes and public parks profoundly influences physical activity and public health. Between 2014 and 2024, the city’s bike lane network surged from 242 to 743 kilometers, complemented by the addition of 15 municipal parks. This urban transformation was linked to increased transport-related cycling, emphasizing the critical role of accessible infrastructure within a 500-meter radius of residents’ homes.

The study’s multidisciplinary approach combined longitudinal surveys of 1,500 residents with geospatial datasets from the Geosampa platform, enabling precise correlation between environmental changes and behavior. Findings indicate that proximity to bike lanes significantly counteracts declining bicycle use trends, suggesting these facilities serve as protective factors promoting sustained physical activity. Such activity reduction directly translates to lower risks of cardiovascular disease, cancer, and improved mental health outcomes like reduced anxiety and depression.

Importantly, the research underscores active transportation infrastructure not only as a logistical planning tool but as a vital public health strategy. By reducing reliance on automobiles, these interventions diminish air pollution and traffic-related accidents, thereby contributing to climate change mitigation efforts. However, the study highlights uneven developments: wealthier neighborhoods received disproportionate infrastructure investments, calling for policy shifts to equip underserved zones with similar amenities.

Beyond infrastructural improvements, the researchers emphasize that sociocultural elements and affordability constraints also limit cycling uptake. Despite increased bike lanes, economic barriers such as the high cost of bicycles and gender disparities in cycling participation suggest that integrated approaches—encompassing recreational street design, bike-sharing expansions, and commuter support facilities—are necessary for meaningful behavioral shifts.

An illustrative testimony comes from a local photographer who transitioned from motorbike to bicycle commuting due to new bike bridges providing direct, safer routes. While embracing cycling’s growth, he voices concerns about road space allocation favoring cars and the emerging challenges of cyclists’ vulnerability amid the rise of faster electric bikes. Additionally, issues of public safety and bike theft remain barriers to broader adoption.

Overall, the findings reveal that São Paulo’s urban planning efforts over the past decade represent a promising model of how thoughtfully designed public open spaces can foster healthier, more sustainable cities. Still, ensuring equitable access and addressing multifaceted cultural and socioeconomic factors remain essential for realizing the full potential of active transport systems.

Subject of Research: Public open spaces and transport-related cycling in urban environments
Article Title: A decade-long study on public open spaces and transport-related cycling in the largest Brazilian city
News Publication Date: 13-Apr-2026
Web References: https://dx.doi.org/10.1016/j.jth.2026.102323
Image Credits: Phelipe Janning/Agência FAPESP

Keywords

Urban planning, Transportation, Public health, Cycling, Active transportation, São Paulo, Infrastructure, Mental health

For decades, the scientific community has recognized the gut microbiome—the intricate ecosystem of bacteria and microorganisms residing within the human intestine—as a potential key player in colorectal cancer development. Yet, the complexity and variability of microbiome data have often obscured clear, reproducible links. Now, an ambitious new study spearheaded by the Mi-EOCRC consortium, which includes pioneering teams at EMBL Heidelberg, has transcended these obstacles by analyzing an unprecedented breadth of data to unearth a universal microbiome signature associated with colorectal cancer.

Garnering insights from an extensive meta-analysis of 27 studies with over 6,700 gut microbiome profiles, the researchers uncovered microbial patterns that remain consistent across diverse populations, sequencing methodologies, and age groups—illuminating a microbial footprint intrinsic to colorectal cancer itself. Their integrative approach not only encompassed stool samples but also expanded to 906 intestinal tissue specimens, revealing striking similarities between microbes colonizing tumors and those present in fecal matter.

This landmark research fundamentally shifted microbiome science by developing innovative computational tools capable of harmonizing heterogeneous datasets produced by different sequencing technologies. Such methodological rigor was critical in overcoming previous barriers of reproducibility that have long plagued microbiome studies. Central to their approach was a bespoke machine learning algorithm adept at categorizing microbiomes along a continuum from ‘healthy’ to ‘cancer-like,’ yielding a quantifiable score that can be leveraged across disparate human gut microbiome datasets, including those derived from dietary interventions.

This algorithmic precision allowed the consortium to isolate a colorectal cancer-associated microbiome signature that transcends traditional cohort boundaries. Intriguingly, the signature appears robust not only in late-stage disease but also in early-onset cases, dispelling prior uncertainty surrounding the microbiome’s role throughout the disease timeline. The discovery underscores the microbiome’s potential as an informative biomarker capable of reflecting the intricate disease ecology.

Moreover, by comparing tumor tissue microbial profiles with those detected in stool, the study illuminated how colorectal cancer’s microbial hallmarks are mirrored across sample types. Although the microbial signature was more readily detectable in advanced tumors or those proximal to the rectum, early-stage lesions exhibited a detectable microbial presence as well. This finding deepens our understanding of tumor-microbiome crosstalk and raises critical questions regarding how microbial communities might influence tumor progression via metabolic and signaling pathways.

Despite these advances, the researchers caution that pre-cancerous adenomas—often the target of preventive strategies—remain notoriously elusive in stool-derived microbiome analyses. The microbial alterations associated with adenomas were subtler and less consistent than those observed in full-fledged cancers. Sophisticated machine learning models specifically aimed at adenoma detection showed variable success across cohorts, highlighting the need for methodological refinement before such tools can make meaningful clinical contributions.

Diet emerged as another pivotal factor shaping cancer-associated microbial patterns. A compelling link was established between low dietary fiber intake and a heightened presence of the colorectal cancer microbiome signature. Conversely, dietary interventions increasing fiber consumption correlated with marked reductions in this cancer-associated microbial pattern. These findings reinforce the concept that diet—and particularly fiber—modulates the gut environment in ways that could impact cancer risk and progression, opening avenues for microbiome-focused preventive strategies rooted in nutrition.

Delving further into microbial taxonomy, the study provided high-resolution insights into Fusobacterium species, bacteria recurrently implicated in colorectal cancer. The researchers delineated notable differences among subspecies, with Fusobacterium nucleatum subsp. animalis exhibiting consistent cancer enrichment worldwide, whereas others showed distinct geographic distributions, predominantly in Asian populations. This nuanced understanding challenges the oversimplification of grouping all Fusobacteria uniformly and underscores the importance of subspecies-level resolution for future microbiome research and therapeutic targeting.

Open science was a cornerstone of this monumental undertaking. By consolidating thousands of publicly available microbiome profiles, the researchers achieved a scale of analysis previously unattainable, setting a new standard for evidence synthesis in microbiome studies. This collective data sharing facilitates reproducible science and paves the way for scalable, global approaches to understanding the microbiome’s role in human disease.

While the study stops short of proposing an immediate diagnostic application, it lays critical groundwork for the development of microbiome-informed clinical tools. Compared to existing non-invasive colorectal cancer screening tests like the fecal immunochemical test, microbiome-based classifiers are not yet on par for sensitivity or specificity. However, the reproducible microbial signature defined here could serve as a foundational reference for future machine-learning models, enabling improved risk stratification and early detection when integrated with other clinical markers.

The implications of this research ripple beyond colorectal cancer alone. The computational tools and conceptual frameworks unveiled may be applied to myriad disease contexts where the microbiome plays a role. Furthermore, the iterative feedback loop between dietary modulation and microbial signatures encourages a personalized medicine approach that incorporates lifestyle factors into disease management.

Finally, this research highlights the intricate dance between host, microbes, and environment that shapes disease landscapes. As microbiome science marches forward, studies like this exemplify the power of interdisciplinary collaboration, computational innovation, and open data stewardship to unravel complex biomedical puzzles, bringing us closer to novel interventions and preventive strategies that could transform patient outcomes worldwide.

Subject of Research: People
Article Title: Meta-analysis reveals microbiome signatures for colorectal cancer that are universal across onset age and sequencing method
News Publication Date: 24-Jun-2026
Web References: http://dx.doi.org/10.1016/j.chom.2026.05.030
Image Credits: Daniela Velasco/EMBL
Keywords: Colorectal cancer, Human microbiota, Gut microbiota

In the rapidly evolving field of geroscience, the quest to translate scientific breakthroughs into tangible clinical benefits has encountered a formidable obstacle: the challenge of selecting trial outcomes that comprehensively reflect the multifaceted effects of geroprotective interventions while satisfying rigorous clinical and regulatory benchmarks. Despite the surge in research advancing our understanding of aging and potential therapies to extend healthspan, clinical trials often struggle to identify endpoints that are simultaneously robust, feasible, and accepted by regulators. This conundrum has impeded the pace at which promising discoveries transition from the bench to bedside.

Traditional endpoints in clinical trials for aging-related therapies have heavily relied on mortality as the gold standard outcome. Mortality is undeniably objective and resonates with regulatory agencies due to its clear clinical significance. However, using mortality as a primary endpoint is frequently impractical in geromedicine trials. The extended timelines required, the large participant populations needed, and ethical considerations make mortality a difficult measure for many intervention studies focused on aging. Given the complexity and prolonged nature of aging processes, mortality-based outcomes often limit the feasibility of clinical research into interventions designed to slow or reverse age-associated decline.

As an alternative, surrogate measures aimed at capturing the quality of extended life, often termed healthspan, have gained attention. Healthspan encompasses diverse dimensions such as physical function, cognitive performance, and biomarker profiles that collectively reflect an individual’s biological and functional status. These measures present a more practical and nuanced depiction of aging’s trajectory and the impact of geroprotective treatments. Nevertheless, healthspan-related endpoints are frequently regarded as “soft” or indirect, necessitating further validation to convince stakeholders of their reliability and clinical relevance. Their subjective nature and variability introduce challenges in affirming their predictive value and regulatory acceptance.

In response to these challenges, researchers have proposed an innovative methodological framework that seeks to harmonize the strengths of both mortality and healthspan measures while mitigating their respective weaknesses. This novel strategy employs hierarchical composite endpoints analyzed through a time-to-worst-event approach, leveraging win statistics to facilitate a pragmatic and scientifically grounded compromise. The essence of this methodology lies in comparing participant pairs within clinical trials based on a predefined, clinically justified hierarchy of events, prioritizing the most severe and objective endpoints such as mortality and major morbidity.

This hierarchical design assigns differing weights to outcomes positioned along a clinical severity spectrum. At the highest tier reside unequivocal events—death and serious clinical incidents—that carry unquestionable clinical importance and regulatory weight. Subsequent tiers integrate healthspan surrogates and biomarker data, contributing valuable subsidiary information that captures subtler yet meaningful intervention effects. Employing this layered approach enables researchers to reflect a fuller spectrum of aging-related outcomes without compromising the prominence of critical clinical endpoints.

Time-to-worst-event analysis serves as a robust statistical tool within this hierarchical framework. By focusing on the timing of the most severe event experienced by an individual, the methodology ensures that the earliest and most significant detriment determines the outcome classification, encompassing the patient’s clinical journey comprehensively. This time-sensitive lens captures not only whether but also when adverse clinical states manifest, providing a dynamic and nuanced perspective critical for aging-related trials, where the temporal dimension is essential.

Central to the proposed framework is the use of “win statistics,” a comparative metric allowing pairwise analysis of trial participants. This statistical method calculates wins, ties, and losses based on the clinical hierarchy, elucidating the overall treatment effect by aggregating these individual pairwise comparisons. The win statistic’s strength lies in its ability to synthesize multifaceted outcomes into a single interpretable measure while maintaining clinical meaning and relevance. Unlike conventional single-endpoint analyses, this approach acknowledges the multidimensional impact of geroprotective interventions.

Importantly, the selection and ordering of outcomes within this hierarchical system demand rigorous clinical and mechanistic justification. Consensus must be achieved among investigators, clinicians, and regulatory authorities to define which events take precedence and how ties are resolved. This transparent and collaborative process assures that composite endpoint construction reflects true clinical priorities and biological plausibility, bolstering regulatory confidence and facilitating trial approval and interpretation. Such an approach safeguards against arbitrary outcome weighting or biased interpretation.

The implications for the future of geromedicine clinical trials are substantial. By embracing hierarchical composite endpoints and win statistics, researchers can design more efficient trials that capture a broad spectrum of treatment effects within feasible timescales and participant cohorts. This methodology sidesteps the pitfalls of relying solely on mortality, while strengthening the evidentiary value of surrogate endpoints and biomarkers. Consequently, promising geroprotective interventions may undergo more straightforward, cost-effective evaluation, accelerating their clinical translation and potential public health impact.

This innovative design also opens pathways for more personalized assessment of intervention efficacy. By integrating multiple health domains and clinical events, trials can better reflect the heterogeneity of aging populations and diverse therapeutic mechanisms. The nuanced outcome assessment permits differential benefits and risks to be dissected, fostering precision geromedicine. Regulators and clinicians alike stand to gain from richer and more actionable data that truly capture quality-of-life improvements alongside traditional survival metrics.

Moreover, the potential regulatory acceptance of hierarchical composite endpoints could catalyze a paradigm shift in aging-related drug development. As the geroscience community demonstrates the validity and utility of such outcomes, regulators may become more amenable to approving longevity therapeutics supported by multifaceted endpoints rather than awaiting protracted mortality data. This regulatory evolution promises to invigorate investment and innovation in geromedicine, an area of growing importance in the context of expanding elderly populations worldwide.

While promising, this approach also entails challenges. It requires meticulous endpoint definition and standardization, robust statistical modeling expertise, and extensive stakeholder engagement to ensure that composite hierarchies are clinically meaningful and mechanistically grounded. Ensuring reproducibility and cross-trial comparability necessitates development of consensus guidelines and open data standards. Ethical considerations surrounding the relative weighting of life quality versus survival further complicate endpoint formulation and require ongoing discourse.

Nevertheless, the proposed hierarchical endpoint framework with win statistics embodies a timely and much-needed advancement addressing a fundamental bottleneck in geroscience clinical research. By bridging regulatory requirements with scientific insights into aging’s multidimensional nature, it lays a robust foundation for accelerated translation of geroprotective therapies. As the population demographic shift intensifies demand for effective aging interventions, such pioneering statistical and clinical innovation is pivotal in transforming geromedicine from promising science into practical medicine.

The work by Abdellatif, Kim, and Kroemer offers a compelling blueprint for the next generation of geromedicine trials. Their integrative approach thoughtfully balances objectivity, clinical relevance, and feasibility, paving the way for interventions that not only extend lifespan but also enhance the quality of those extended years. The advent of hierarchical composite endpoints guided by win statistics may ultimately revolutionize how aging therapies are evaluated, deployed, and embraced by healthcare systems worldwide, heralding a new era in age-related healthcare.

As this methodology gains traction, collaborative efforts across academia, industry, and regulatory bodies will be critical to refine, validate, and implement hierarchical endpoints in ongoing and future geroscience trials. Real-world application and longitudinal data will provide further insights to optimize outcome hierarchies and better reflect patient-centered benefits. Such collective progress holds the promise to unlock the full potential of geroprotective interventions, reshaping the landscape of aging medicine.

In essence, hierarchical composite endpoints and win statistic analysis emerge as a paradigm-shifting solution to the age-old dilemma of measuring meaningful outcomes in aging research. By embracing complexity and clinical priorities simultaneously, this approach captures the multidimensional health impacts of geromedicine interventions with rigor and pragmatism. The coming years will reveal how this innovation transforms clinical trial design and ultimately delivers on the long-awaited promise of prolonging both lifespan and healthspan.

Subject of Research: Geroscience clinical trial outcome measurement; hierarchical composite endpoints in geromedicine studies; win statistics for multidimensional aging-related outcomes

Article Title: Hierarchical endpoints and win statistics for geromedicine trials

Article References:
Abdellatif, M., Kim, Y. & Kroemer, G. Hierarchical endpoints and win statistics for geromedicine trials. Nat Aging (2026). https://doi.org/10.1038/s43587-026-01158-3

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s43587-026-01158-3

In a groundbreaking study challenging prevailing assumptions about climate policy, German politicians appear to underestimate public support for climate action, suggesting a disconnect that could shape future legislative efforts. This research, recently published in Communications Earth & Environment, involved a comprehensive survey of over 6,000 German political figures combined with two robust population samples, shedding new light on the perceptions of climate-related public opinion within political domains.

The study’s core methodology involved contacting 6,074 German politicians via official email addresses between September and November 2024. These emails invited recipients to participate in a concise, five-minute online survey on “Trends in German Society,” deliberately omitting any direct reference to climate change in an effort to reduce bias. Despite the considerable size of the outreach, the overall final completion rate after stringent data cleaning—including a threshold where respondents completing less than half of the survey were excluded—yielded 1,599 high-quality responses. This cohort formed the backbone of the political sample for in-depth analysis.

Respondents were first provided a clear, scientific definition of global warming to ensure a consistent understanding across participants. This standardization was essential for eliciting valid attitudes relating to perceived problem awareness, policy acceptance, and willingness to engage in financial contributions toward climate mitigation efforts. The survey asked about politicians’ perceptions of how problematic the average German citizen finds climate-damaging behaviors and the corresponding desire for government intervention to reduce such actions. This dual focus aimed to assess both the perceived societal concern and the appetite for political support in addressing climate issues.

One of the critical findings centers on the perceived public acceptance of climate policies. Politicians were queried about communication and informational initiatives, the imposition of taxes on environmentally harmful products and behaviors, as well as stricter laws and regulations. Results indicated that politicians systematically underestimated the level of public support for each type of intervention, revealing a sizable perception gap that may influence hesitancy or delay in implementing ambitious policies.

Additional layers of the survey explored perceived willingness among citizens to contribute financially to climate action. Two specific metrics were used: the number of people believed to be willing to donate 1% of their household income monthly toward climate causes, and the expected amount of microdonations from a hypothetical €1 earned by survey participation. The politicians’ conservative estimates in these financial willingness measures contrasted with actual data derived from representative surveys of the German population, underscoring a potential underappreciation of public commitment.

Complementing the political survey, two population samples were simultaneously analyzed. The first was a nationally representative online cohort of 1,034 German residents aged 16 and older, recruited through the professional survey company Kantar. This sample’s data helped benchmark real public attitudes toward climate problem awareness, governmental support desires, and acceptance of policy measures. The second incorporated 1,000 participants from the global Gallup World Poll, representing a broad cross-section of the German populace, further reinforcing the validity of the findings.

The population samples consistently demonstrated higher levels of problem recognition and stronger endorsement for governmental action on climate change than the political respondents presumed. Notably, willingness to financially support climate initiatives was markedly higher among the general public than politicians estimated. This disparity points toward a systemic underestimation within the political elite regarding their constituents’ readiness for meaningful climate policies.

Such findings hold significant implications for political decision-making. By misjudging the public’s attitudes, legislators and party leaders may refrain from advancing or supporting robust climate legislation for fear of voter backlash or electoral risk. This dynamic could partly explain the sluggish pace of climate policy adoption in Germany despite mounting scientific urgency and popular concern.

The study also incorporates demographic variables from the political cohort—party membership, mandate level, government versus opposition status—but the perception gap in climate support appears pervasive across these strata. The researchers carefully mitigated selection biases by anonymizing survey topics and limiting survey length to encourage participation, thus strengthening the generalizability of their conclusions.

Moreover, the research underscores a broader phenomenon in democratic governance: the critical importance of accurate awareness of public opinion among policymakers. Misperceptions can skew policy priorities and stall necessary systemic transformation, especially in deeply divisive or complex issues such as climate change. This study contributes empirical evidence to the discourse, advocating for enhanced communication channels and feedback mechanisms between citizens and their elected representatives.

The implications extend beyond Germany, serving as a cautionary tale for democracies worldwide. As climate crises accelerate, aligning political perceptions with grassroots realities is paramount to fostering effective, timely policy responses. Future research might explore interventions that improve politicians’ insight into public sentiment or measure the impacts of corrected perceptions on policy enactment.

Researchers also highlight the need for continuous, high-resolution public opinion tracking using varied methodologies, including direct surveys with policymakers and general population samples. This multi-angle approach ensures robust cross-validation and prevents siloed misunderstandings from dampening political momentum on urgent environmental challenges.

By revealing that German politicians substantially undervalue public backing for climate action, this study challenges political assumptions and calls for strategic reforms in policymaker engagement with constituents. Increased awareness of genuine public support could embolden policymakers to champion ambitious climate initiatives, potentially reshaping Germany’s environmental trajectory.

The convergence of rigorous survey methods, large sample sizes, and thorough demographic controls lends significant credibility to these revelations. Ultimately, bridging the gap between political perception and public reality represents a critical step to unlocking proactive climate governance capable of meeting the demands of planetary stewardship.

As Germany positions itself as a leader in climate policy, this study’s insights serve as a powerful reminder that public opinion is not only a metric but a dynamic resource to be understood and harnessed. Greater transparency and dialogue between politicians and citizens might unlock untapped political will, enhancing collective climate action efficacy.

In conclusion, the evidence points to a pervasive issue: political misjudgment of climate support that risks impeding crucial policy advancements. Addressing this perceptual shortfall may catalyze transformative environmental legislation, aligning political action with the robust enthusiasm evident among the German populace.

Subject of Research: Public perceptions of climate action support among German politicians compared to the general population

Article Title: Public support for climate action is underestimated in the German political domain

Article References:
Sevincer, A.T., Hostlowsky, L., Styhler, F. et al. Public support for climate action is underestimated in the German political domain. Commun Earth Environ 7, 543 (2026). https://doi.org/10.1038/s43247-026-03721-7

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s43247-026-03721-7